The American Society for Bone and Mineral Research has developed a set of treatment recommendations for the prevention of secondary fracture in patients 65 years and older who have had a hip or vertebral fracture. There are 13 recommendations. In this slideshow, we highlight the recommendations beginning with improved doctor-patient communication.
The cost of treating osteoporosis in the United states has risen 118 percent over the last 19 years, shows an analysis presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.
Shared decision making should be employed in deciding on the best course of treatment for postmenopausal women with osteoporosis, experts say. In this slideshow, we highlight some of the key recommendations for diagnosing osteoporosis and assessing fracture risk in postmenopausal women.
Which additional bone traits, besides bone mineral density, can be used to determine fracture risk? Authors of a new study sought to find out.
Contrary to current guideline recommendations, a new review argues against routine coeliac disease screening for osteoporosis patients.
A new study found statin use is associated with a decreased risk of osteoporosis, hip fracture, and vertebral fracture in stroke patients.
A patient's genetic predisposition to low bone mineral density can increase their risk for osteoporotic fractures, according to a new genome-wide association study.
Authors of a new study devised a new algorithm that can help physicians identify and manage diabetic patients at increased fracture risk.
Will the new recommendations affect your approach to osteoporosis screening and treatment? Scroll through our quick slideshow to get all the highlights.
A bisphosphonate drug holiday linked to a 20% rise in hip fractures in older women, according to a new study.